Calmasol-440, solution for infusion for cattle, sheep and pigs
Calmasol-440, solution for infusion for cattle, sheep and pigs
Authorised
- Calcium gluconate monohydrate
- Magnesium chloride hexahydrate
- Boric acid
Product identification
Medicine name:
Calmasol-440, solution for infusion for cattle, sheep and pigs
Calmafusion 380mg/60mg/50mg, otopina za infuziju, za goveda, ovce i svinje
Active substance:
- Calcium gluconate monohydrate
- Magnesium chloride hexahydrate
- Boric acid
Target species:
-
Cattle
-
Sheep
-
Pig
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
Calcium gluconate monohydrate380.00milligram(s)1.00millilitre(s)
-
Magnesium chloride hexahydrate60.00milligram(s)1.00millilitre(s)
-
Boric acid50.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for infusion
Withdrawal period by route of administration:
-
Intravenous use
-
Cattle
-
Meat and offal0day
-
Milk0hour
-
-
Sheep
-
Meat and offal0day
-
Milk0hour
-
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA12AX
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Package description:
- Graduated polypropylene bottle, closed with a bromobutyl rubber stopper and secured with an aluminium cap. 12x500 ml.
- Graduated polypropylene bottle, closed with a bromobutyl rubber stopper and secured with an aluminium cap. 1x500 ml.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Interchemie Werken De Adelaar Eesti AS
Marketing authorisation date:
Manufacturing sites for batch release:
- Interchemie Werken De Adelaar Eesti AS
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/19-01/694
Date of authorisation status change:
Reference member state:
-
Estonia
Procedure number:
- EE/V/0104/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 18/02/2025
How useful was this page?: